Strategies for Clinical Imaging in Diabetes
You may also be interested in the Benign and Malignant Exocrine Pancreatic Disease and the Strategies for Clinical Imaging in Diabetes meeting.
The ability to noninvasively image the cell types of the pancreatic islet and their function, particularly the beta cell, would allow diabetes researchers to observe and learn about the natural history of diabetes in living human beings. Most of the information we have currently about the fate of the insulin-producing cells comes from single snapshots taken in cadaver pancreas from people in various stages of diabetes. At this time, there are several promising imaging agents in various stages of development and validation.
This workshop is designed to provide a forum for discussion of the state of the art of in vivo imaging of the pancreatic islet beta cell mass and function, and the next steps toward this important goal.
Gary Cline, Yale University
Martin Gotthardt, Radboud University Nijmegen, Netherlands
Paul E. Harris, Columbia University
Anna Moore, Michigan State University
Alvin Powers, Vanderbilt University
Dana Anderson, NIDDK, NIH
Olivier Blondel, NIDDK, NIH
Maren R. Laughlin, NIDDK, NIH
Lalitha Shankar, NCI, NIH
January 5, 2020